Tabatabaei Pedram, Visse Eward, Bergström Per, Brännström Thomas, Siesjö Peter, Bergenheim A Tommy
Department of Clinical Neuroscience, Neurosurgery, Umea University, 901 85, Umeå, Sweden.
Department of Clinical Science, Lund University Hospital, 221 85, Lund, Sweden.
J Neurooncol. 2017 Jan;131(1):83-92. doi: 10.1007/s11060-016-2271-1. Epub 2016 Sep 23.
The knowledge of response to radiation in the immuno-microenvironment of high grade gliomas is sparse. In vitro results have indicated an inflammatory response of myeloid cells after irradiation. Therefore, microdialysis was used to verify whether this is operative in tumor tissue and brain adjacent to tumor (BAT) after clinical radiotherapy of patients with high grade glioma. Stereotactic biopsies and implantation of microdialysis catheters in tumor tissue and BAT were performed in eleven patients with high-grade glioma. The patients were given daily radiation fractions of 2-3.4 Gy. Microdialysis samples were collected before radiotherapy and during the first five days of radiation. Cytokines, glucose metabolites, glutamate and glycerol were analyzed. Immunohistochemistry was performed to detect macrophages (CD68) and monocytes (CD163) as well as IL-6, IL-8 and MCP-1. A significant increase of IL-8, MCP-1 and MIP-1a were detected in tumor tissue already after the first dose of radiation and increased further during 5 days of radiation. IL-6 did also increase but after five fractions of radiation. In BAT, the cytokine response was modest with significant increase of IL-8 after third dose of radiation. We found a positive correlation between baseline IL-8 and IL-6 microdialysis levels in tumor tissue and survival. Glucose metabolites or glycerol and glutamate did not change during radiation. In all tumors staining for macrophages was demonstrated. IL-6 was found in viable tumor cells while MCP-1 was demonstrated in macrophages or tumor matrix. Our findings suggest that radiation induces a rapid enhancement of the prevailing inflammation in high-grade glioma tissue. The microdialysis technique is feasible for this type of study and could be used to monitor metabolic changes after different interventions.
关于高级别胶质瘤免疫微环境中对辐射反应的了解很少。体外研究结果表明,辐射后髓样细胞会产生炎症反应。因此,我们采用微透析技术来验证这一现象在高级别胶质瘤患者临床放疗后的肿瘤组织及肿瘤周围脑组织(BAT)中是否存在。对11例高级别胶质瘤患者进行了立体定向活检,并在肿瘤组织和BAT中植入微透析导管。患者每天接受2 - 3.4 Gy的分次放疗。在放疗前及放疗的前五天收集微透析样本。分析细胞因子、葡萄糖代谢产物、谷氨酸和甘油。进行免疫组织化学检测巨噬细胞(CD68)、单核细胞(CD163)以及白细胞介素-6(IL-6)、白细胞介素-8(IL-8)和单核细胞趋化蛋白-1(MCP-1)。在首次放疗后,肿瘤组织中IL-8、MCP-1和MIP-1α就显著增加,并在放疗的5天内进一步升高。IL-6也有所增加,但在放疗五次后才出现。在BAT中,细胞因子反应较弱,在第三次放疗后IL-8显著增加。我们发现肿瘤组织中基线IL-8和IL-6微透析水平与生存率呈正相关。放疗期间葡萄糖代谢产物、甘油和谷氨酸没有变化。在所有肿瘤中均检测到巨噬细胞染色。在存活的肿瘤细胞中发现了IL-6,而在巨噬细胞或肿瘤基质中发现了MCP-1。我们的研究结果表明,辐射可迅速增强高级别胶质瘤组织中普遍存在的炎症反应。微透析技术适用于此类研究,可用于监测不同干预后的代谢变化。